Skip to main content
CLBCore Laboratories Inc.Sell4.7·$11.46-0.95%
Open full analysis

Core Laboratories Inc. (CLB) Stock Analysis

Catalyst-Driven edge

SellVALUE-TRAP 1/5Moderate Confidence

Energy · Oil & Gas Equipment & Services

Sell if holding. Momentum 3.2/10 is below the 5.0 floor at $11.46 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Weak overall score: 4.7/10; Weak growth.

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description... Read more

$11.46+17.5% A.UpsideScore 4.7/10#30 of 37 Oil & Gas Equipment & Services
QualityF-score7 / 9FCF yield8.37%
IncomeYield0.35%(5y avg 0.22%)Payout6.56%sustainable
Stop $10.66Target $13.46(analyst − 15%)A.R:R 1.8:1
Analyst target$15.83+38.2%3 analysts
$13.46our TP
$11.46price
$15.83mean
$22

Sell if holding. Momentum 3.2/10 is below the 5.0 floor at $11.46 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Weak overall score: 4.7/10; Weak growth. Chart setup: No clear chart pattern; technical signals are mixed. Score 4.7/10, moderate confidence.

Passes 7/8 gates (favorable risk/reward ratio, clean insider activity, no SEC red flags, news events none recent, earnings proximity 25d clear, semi cycle peak clear, materials cycle peak clear). Fails on weak momentum. Suitability: speculative.

TrendMatrix Research · upcoming catalyst calendar

Upcoming dated catalysts

Wed, Jul 29, 202625d to earnings· next earnings call

Thesis

Rewards
Strong earnings beat streak (3/4)
Attractive valuation
Risks
Weak overall score: 4.7/10
Weak growth
Negative momentum

Key Metrics

P/E (TTM)18.8
P/E (Fwd)16.5
Mkt Cap$528M
EV/EBITDA11.2
Profit Mgn5.5%
ROE11.1%
Rev Growth-1.4%
Beta1.01
Dividend0.35%
Rating analysts10

Quality Signals

Piotroski F7/9

Options Flow

P/C0.94neutral
IV88%elevated

Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.

Show full disclosure ▾

About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.

Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.

Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.

No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.

No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.

Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.

Methodology · Editorial policy & full disclaimer

Rating Breakdown

3 floor-breakers

Price action weak — below key moving averages, no momentum carry. Needs a base before trend-continuation setups apply.static

Obv
1.0
Ma Position
2.2
Volume
2.7
Rsi
3.5
Macd
6.6
Volume distribution (falling OBV)Below 200-MA but MA still rising (+1.5%/30d) — pullback in uptrend, not confirmed weakness

Revenue shrinking — -1.4% YoY. Growth thesis broken unless recovery story develops.static

Revenue Growth
2.1
Earnings Growth
4.8
Declining revenue: -1%

Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static

Growth Rank
2.8
Quality Rank
5.6
Value Rank
7.3
GatesMomentum 3.2<4.5A.R:R 1.8 ≥ 1.5Insider activity: OKNo SEC red flagsNEWS EVENTS NONE RECENTEARNINGS PROXIMITY 25d clearSEMI CYCLE PEAK CLEARMATERIALS CYCLE PEAK CLEARSuitability: Speculative
RSI
30 · Neutral
20D MA 50D MA 200D MADEATH CROSSSupport $10.51Resistance $13.95

Price Targets

$11
$13
A.Upside+17.5%
A.R:R1.8:1

Position Sizing

ConvictionNone
Suggested %0.5%
Max %1%
RegimeSteady

Risk Alerts

! momentum at 3.2 (below the engine's 4.5 threshold)

Earnings

B
B
B
M
3/4 beats
Next Earnings2026-07-29 (25d)

Verdict History

reverse chrono — latest first
Loading history...
Verdicts are recorded on every nightly pipeline run. Rows capture transitions (verdict flips, score deltas ≥0.3, entry/TP/SL changes). Rows with a ▶ can be expanded to see the change reason. Aggregate cohort performance is tracked in the recommendation ledger.
Frequently Asked Questions
Is CLB stock a buy right now?

Sell if holding. Momentum 3.2/10 is below the 5.0 floor at $11.46 — engine's falling-knife protection flags exit rather than catching a breakdown. Specifics: Weak overall score: 4.7/10; Weak growth. Chart setup: No clear chart pattern; technical signals are mixed. Prior stop was $10.66. Score 4.7/10, moderate confidence.

What is the CLB stock price target?

Take-profit target: $13.46 (+17.5% upside). Prior stop was $10.66. Stop-loss: $10.66.

What are the risks of investing in CLB?

Weak overall score: 4.7/10; Weak growth; Negative momentum.

Is CLB overvalued or undervalued?

Core Laboratories Inc. trades at a P/E of 18.8 (forward 16.5). TrendMatrix value score: 7.2/10. Verdict: Sell.

What do analysts say about CLB?

10 analysts cover CLB with a consensus score of 2.4/5. Average price target: $16.

What does Core Laboratories Inc. do?Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and...

Core Laboratories Inc. provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and natural gas from its clients' reservoirs. It offers laboratory-based analytical and field services to characterize properties of crude oil and oil delivered products; and proprietary and joint industry studies, as well as services that support carbon capture, utilization and storage, geothermal projects, and the evaluation and appraisal of mining activities. The Production Enhancement segment provides services and products relating to reservoir well completions, perforations, stimulations, production, and well abandonment. It offers integrated diagnostic services to evaluate and monitor the effectiveness of well completions and to develop solutions to improve the effectiveness of enhanced oil recovery projects. The company markets and sells its products through a combination of sales representatives, technical seminars, trade shows, and print advertising, as well as through distributors. Core Laboratories Inc. was founded in 1936 and is based in Houston, Texas.

Related stocks: USAC (USA Compression Partners, LP) · NGS (Natural Gas Services Group, Inc) · FLOC (Flowco Holdings Inc.) · WHD (Cactus, Inc. Class A Common Sto) · NESR (National Energy Services Reunit)
Home Stocks CLB

Latest news

No recent news